News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
852,962 Results
Type
Article (86888)
Company Profile (704)
Press Release (765369)
Multimedia
Podcasts (147)
Webinars (19)
Section
Business (232823)
Career Advice (4133)
Deals (39763)
Drug Delivery (129)
Drug Development (91111)
Employer Resources (198)
FDA (18190)
Job Trends (17364)
News (396857)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1572)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (401)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (392)
Cancer (3098)
Cardiovascular disease (249)
Career advice (3541)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74324)
Collaboration (1111)
Company closure (3)
Compensation (711)
Complete response letters (34)
COVID-19 (2905)
CRISPR (67)
C-suite (358)
Cystic fibrosis (121)
Data (3094)
Decentralized trials (2)
Denatured (51)
Depression (77)
Diabetes (380)
Diagnostics (6980)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (183)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (135)
Earnings (97528)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131478)
Executive appointments (909)
FDA (19937)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1019)
Gene editing (147)
Generative AI (40)
Gene therapy (439)
GLP-1 (937)
Government (5263)
Grass and pollen (6)
Guidances (181)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3102)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (593)
Leadership (26)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (433)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (446)
MASH (99)
Medical device (14733)
Medtech (14738)
Mergers & acquisitions (22585)
Metabolic disorders (968)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (143)
Neuropsychiatric disorders (42)
Neuroscience (2330)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (125)
Parkinson's disease (201)
Partnered (25)
Patents (320)
Patient recruitment (173)
Peanut (55)
People (65727)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22939)
Phase II (32271)
Phase III (24300)
Pipeline (1703)
Policy (243)
Postmarket research (3552)
Preclinical (10359)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (527)
Real estate (7402)
Recruiting (76)
Regulatory (27184)
Reports (61)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (94)
Vaccines (919)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (95)
Last 7 days (407)
Last 30 days (2041)
Last 365 days (34013)
2025 (18501)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50541)
Australia (8878)
California (7804)
Canada (2417)
China (728)
Colorado (340)
Connecticut (348)
Delaware (205)
Europe (115949)
Florida (1158)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (743)
India (33)
Indiana (386)
Iowa (18)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1105)
Massachusetts (5969)
Michigan (276)
Minnesota (486)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2192)
New Mexico (31)
New York (2187)
North Carolina (1247)
North Dakota (10)
Northern California (3364)
Ohio (252)
Oklahoma (17)
Oregon (48)
Pennsylvania (1663)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2889)
Tennessee (129)
Texas (1198)
United States (29465)
Utah (231)
Virginia (214)
Washington D.C. (80)
Washington State (690)
West Virginia (4)
Wisconsin (86)
There are 852,962 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
July 17, 2025
·
10 min read
ALS
Patients Fight for Access to BrainStorm’s ALS Drug After Expanded Access Data ‘Defy Logic’
Participants in trials of BrainStorm Cell Therapeutics’ NurOwn filed a Citizens’ Petition with the FDA earlier this month seeking a new review of the stem cell therapy that was rejected in 2022 based on real-world data and 90% survival in an expanded access program.
July 17, 2025
·
9 min read
·
Heather McKenzie
Layoffs
Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff
Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta Therapeutics adds a black box warning to the gene therapy for acute liver injury and failure and parts with more than a third of employees.
July 16, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 16, 2025
·
1 min read
Press Releases
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
July 16, 2025
·
1 min read
Press Releases
TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
July 16, 2025
·
1 min read
Press Releases
Genascence Announces U.S. Food and Drug Administration Grants Regenerative Medicine Advanced Therapy Designation to GNSC-001 for Knee Osteoarthritis (OA)
July 16, 2025
·
4 min read
Press Releases
Humanetics Corporation to Present at Upcoming Military Medical and Defense Conferences
July 16, 2025
·
3 min read
Press Releases
Prima Mente Launches Pleiades, a Large-Scale Human Whole-Epigenome Foundation Model with Clinical Applications for Alzheimer’s Disease
July 16, 2025
·
4 min read
Press Releases
OmniAb to Report Second Quarter 2025 Financial Results on August 6
July 16, 2025
·
1 min read
1 of 85,297
Next
